|
1
|
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
|
N Engl J Med
|
2008
|
13.02
|
|
2
|
Oncogene-induced senescence as an initial barrier in lymphoma development.
|
Nature
|
2005
|
9.16
|
|
3
|
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.
|
Nat Med
|
2010
|
4.76
|
|
4
|
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking.
|
Science
|
2005
|
3.58
|
|
5
|
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.
|
Blood
|
2011
|
3.32
|
|
6
|
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
|
Blood
|
2011
|
3.28
|
|
7
|
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
|
J Clin Oncol
|
2011
|
3.17
|
|
8
|
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
|
J Clin Oncol
|
2011
|
3.09
|
|
9
|
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.
|
Blood
|
2009
|
3.07
|
|
10
|
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
|
J Clin Oncol
|
2011
|
2.88
|
|
11
|
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
|
Blood
|
2006
|
2.87
|
|
12
|
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
|
Blood
|
2012
|
2.69
|
|
13
|
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
|
J Clin Oncol
|
2010
|
2.38
|
|
14
|
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
|
J Clin Oncol
|
2011
|
2.26
|
|
15
|
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
|
J Clin Oncol
|
2009
|
2.23
|
|
16
|
RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
|
J Clin Oncol
|
2011
|
2.11
|
|
17
|
Persistent malignant stem cells in del(5q) myelodysplasia in remission.
|
N Engl J Med
|
2010
|
2.11
|
|
18
|
Breast carcinoma during pregnancy. International recommendations from an expert meeting.
|
Cancer
|
2006
|
2.04
|
|
19
|
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.
|
Sci Transl Med
|
2014
|
2.00
|
|
20
|
Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice.
|
Cell
|
2007
|
1.96
|
|
21
|
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.
|
Blood
|
2010
|
1.96
|
|
22
|
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response.
|
Blood
|
2006
|
1.93
|
|
23
|
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
|
Cancer Res
|
2005
|
1.84
|
|
24
|
Breast cancer susceptibility: current knowledge and implications for genetic counselling.
|
Eur J Hum Genet
|
2008
|
1.82
|
|
25
|
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.
|
Blood
|
2005
|
1.82
|
|
26
|
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
|
J Clin Oncol
|
2011
|
1.79
|
|
27
|
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.
|
Blood
|
2012
|
1.68
|
|
28
|
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.
|
Blood
|
2011
|
1.65
|
|
29
|
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
|
J Clin Oncol
|
2010
|
1.64
|
|
30
|
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
|
Blood
|
2013
|
1.62
|
|
31
|
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry.
|
Rapid Commun Mass Spectrom
|
2004
|
1.57
|
|
32
|
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.
|
Blood
|
2010
|
1.56
|
|
33
|
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
|
J Clin Oncol
|
2003
|
1.49
|
|
34
|
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
|
J Clin Oncol
|
2010
|
1.46
|
|
35
|
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.
|
Blood
|
2004
|
1.39
|
|
36
|
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
|
Blood
|
2002
|
1.38
|
|
37
|
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
|
Blood
|
2007
|
1.37
|
|
38
|
Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
|
Gastroenterology
|
2012
|
1.37
|
|
39
|
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).
|
Blood
|
2013
|
1.33
|
|
40
|
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
|
Haematologica
|
2010
|
1.32
|
|
41
|
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.
|
Haematologica
|
2009
|
1.31
|
|
42
|
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
|
Blood
|
2007
|
1.31
|
|
43
|
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
|
Blood
|
2011
|
1.30
|
|
44
|
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
|
J Clin Oncol
|
2012
|
1.28
|
|
45
|
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
|
Oncogene
|
2003
|
1.27
|
|
46
|
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.
|
Gastroenterology
|
2005
|
1.25
|
|
47
|
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
|
Blood
|
2012
|
1.25
|
|
48
|
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.
|
J Community Genet
|
2011
|
1.23
|
|
49
|
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.
|
Blood
|
2009
|
1.23
|
|
50
|
Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
|
Arthritis Rheum
|
2005
|
1.23
|
|
51
|
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
|
Haematologica
|
2005
|
1.21
|
|
52
|
Refined histopathologic scoring system improves power to detect colitis QTL in mice.
|
Mamm Genome
|
2004
|
1.20
|
|
53
|
Radiation rescue: mesenchymal stromal cells protect from lethal irradiation.
|
PLoS One
|
2011
|
1.17
|
|
54
|
Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
|
Ann Hematol
|
2009
|
1.17
|
|
55
|
MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development.
|
Int J Cancer
|
2011
|
1.15
|
|
56
|
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
|
BMC Med Genet
|
2005
|
1.15
|
|
57
|
Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling.
|
Clin Cancer Res
|
2005
|
1.14
|
|
58
|
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
|
Blood
|
2013
|
1.12
|
|
59
|
Parthenogenetic stem cells for tissue-engineered heart repair.
|
J Clin Invest
|
2013
|
1.11
|
|
60
|
Tumor cells escape suicide gene therapy by genetic and epigenetic instability.
|
Blood
|
2004
|
1.11
|
|
61
|
Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses.
|
Physiol Genomics
|
2006
|
1.08
|
|
62
|
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.
|
J Clin Invest
|
2010
|
1.07
|
|
63
|
Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review.
|
Eur J Hum Genet
|
2007
|
1.05
|
|
64
|
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.
|
J Exp Med
|
2012
|
1.05
|
|
65
|
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.
|
J Med Genet
|
2013
|
1.05
|
|
66
|
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.
|
Blood
|
2010
|
1.05
|
|
67
|
Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas.
|
Genes Chromosomes Cancer
|
2006
|
1.04
|
|
68
|
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML.
|
Blood
|
2012
|
1.04
|
|
69
|
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
|
Haematologica
|
2005
|
1.02
|
|
70
|
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.
|
Mol Ther
|
2012
|
1.01
|
|
71
|
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
|
J Clin Oncol
|
2009
|
1.01
|
|
72
|
Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer.
|
J Pathol
|
2009
|
1.01
|
|
73
|
Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation.
|
Haematologica
|
2009
|
1.01
|
|
74
|
Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16).
|
Genes Chromosomes Cancer
|
2004
|
1.00
|
|
75
|
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations.
|
Genes Chromosomes Cancer
|
2012
|
1.00
|
|
76
|
Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses.
|
Ann Hematol
|
2006
|
1.00
|
|
77
|
Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.
|
Leuk Res
|
2010
|
1.00
|
|
78
|
Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
|
Hepatology
|
2005
|
0.98
|
|
79
|
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype.
|
Haematologica
|
2011
|
0.98
|
|
80
|
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.
|
Ann Hematol
|
2012
|
0.97
|
|
81
|
Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma.
|
Mod Pathol
|
2008
|
0.96
|
|
82
|
Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
|
Genes Chromosomes Cancer
|
2003
|
0.96
|
|
83
|
Clinicopathologic correlations of genomic gains and losses in follicular lymphoma.
|
J Clin Oncol
|
2002
|
0.96
|
|
84
|
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
|
Haematologica
|
2009
|
0.96
|
|
85
|
Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes*.
|
Eur J Haematol
|
2009
|
0.95
|
|
86
|
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.
|
J Clin Oncol
|
2011
|
0.95
|
|
87
|
Concise review: managing genotoxicity in the therapeutic modification of stem cells.
|
Stem Cells
|
2011
|
0.94
|
|
88
|
AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability.
|
Cancer Res
|
2006
|
0.94
|
|
89
|
Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.
|
Proc Natl Acad Sci U S A
|
2004
|
0.94
|
|
90
|
Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci.
|
Int J Cancer
|
2002
|
0.94
|
|
91
|
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
|
J Clin Oncol
|
2007
|
0.94
|
|
92
|
Telomere shortening and chromosomal instability in myelodysplastic syndromes.
|
Genes Chromosomes Cancer
|
2010
|
0.94
|
|
93
|
Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.
|
Mol Ther
|
2007
|
0.94
|
|
94
|
Effects of BisGMA on glutathione metabolism and apoptosis in human gingival fibroblasts in vitro.
|
Biomaterials
|
2004
|
0.93
|
|
95
|
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
|
Blood
|
2012
|
0.93
|
|
96
|
Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
|
Clin Gastroenterol Hepatol
|
2006
|
0.93
|
|
97
|
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
|
Blood
|
2014
|
0.93
|
|
98
|
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
|
Haematologica
|
2007
|
0.92
|
|
99
|
Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome.
|
Hum Mol Genet
|
2006
|
0.92
|
|
100
|
Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions.
|
Mod Pathol
|
2008
|
0.92
|
|
101
|
Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH.
|
Genes Chromosomes Cancer
|
2010
|
0.92
|
|
102
|
Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias.
|
Blood
|
2009
|
0.91
|
|
103
|
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.
|
Ann Hematol
|
2012
|
0.91
|
|
104
|
BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.
|
Cancer Genet Cytogenet
|
2005
|
0.90
|
|
105
|
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study.
|
Ann Hematol
|
2005
|
0.90
|
|
106
|
Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
|
Br J Haematol
|
2005
|
0.89
|
|
107
|
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
|
Eur J Haematol
|
2011
|
0.88
|
|
108
|
Consider family history.
|
Dtsch Arztebl Int
|
2014
|
0.88
|
|
109
|
Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
|
Blood
|
2012
|
0.88
|
|
110
|
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.
|
Genes Chromosomes Cancer
|
2012
|
0.87
|
|
111
|
Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
|
Leuk Res
|
2009
|
0.87
|
|
112
|
Standardised fluorescence in situ hybridisation in cytological and histological specimens.
|
Virchows Arch
|
2005
|
0.87
|
|
113
|
Loss of Dnd1 facilitates the cultivation of genital ridge-derived rat embryonic germ cells.
|
Exp Cell Res
|
2011
|
0.85
|
|
114
|
Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).
|
Eur J Hum Genet
|
2010
|
0.85
|
|
115
|
Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines.
|
Chromosome Res
|
2011
|
0.85
|
|
116
|
Genetic instability of modified stem cells - a first step towards malignant transformation?
|
Am J Stem Cells
|
2013
|
0.84
|
|
117
|
Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia.
|
Br J Haematol
|
2011
|
0.84
|
|
118
|
Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution.
|
Cancer Genet Cytogenet
|
2007
|
0.84
|
|
119
|
High-affinity neurotrophin receptors and ligands promote leukemogenesis.
|
Blood
|
2008
|
0.84
|
|
120
|
Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology.
|
Lung Cancer
|
2011
|
0.84
|
|
121
|
Histopathological criteria and selection algorithms for BRCA1 genetic testing.
|
Cancer Genet Cytogenet
|
2009
|
0.84
|
|
122
|
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.
|
Haematologica
|
2010
|
0.84
|
|
123
|
Communicating BRCA1 and BRCA2 genetic test results.
|
J Clin Oncol
|
2006
|
0.83
|
|
124
|
Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
|
Transplantation
|
2011
|
0.83
|
|
125
|
Analysis of array-CGH data using the R and Bioconductor software suite.
|
Comp Funct Genomics
|
2009
|
0.83
|
|
126
|
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
|
Genes Chromosomes Cancer
|
2008
|
0.83
|
|
127
|
MicroRNA miR-548d is a superior regulator in pancreatic cancer.
|
Pancreas
|
2012
|
0.82
|
|
128
|
Spectral karyotyping and fluorescence in situ hybridization of murine cells.
|
Methods Mol Biol
|
2009
|
0.82
|
|
129
|
Serum- and stromal cell-free hypoxic generation of embryonic stem cell-derived hematopoietic cells in vitro, capable of multilineage repopulation of immunocompetent mice.
|
Stem Cells Transl Med
|
2012
|
0.82
|
|
130
|
Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management.
|
Breast Cancer Res Treat
|
2012
|
0.82
|
|
131
|
Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic.
|
PLoS One
|
2012
|
0.82
|
|
132
|
Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study.
|
Leuk Res
|
2009
|
0.81
|
|
133
|
A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type.
|
Int J Oncol
|
2012
|
0.81
|
|
134
|
The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
|
BMC Cell Biol
|
2008
|
0.81
|
|
135
|
Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
|
Community Genet
|
2003
|
0.80
|
|
136
|
Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.
|
Eur J Hum Genet
|
2012
|
0.80
|
|
137
|
The CpG island methylator phenotype in breast cancer is associated with the lobular subtype.
|
Epigenomics
|
2014
|
0.80
|
|
138
|
Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia.
|
Cancers (Basel)
|
2013
|
0.80
|
|
139
|
Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency.
|
Haematologica
|
2011
|
0.80
|
|
140
|
Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
|
Pathobiology
|
2008
|
0.80
|
|
141
|
Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology.
|
Haematologica
|
2013
|
0.80
|
|
142
|
Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML.
|
Ann Hematol
|
2010
|
0.80
|
|
143
|
Induced G1 phase arrest of fast-dividing cells improves the quality of genomic profiles generated by array-CGH.
|
Biotechniques
|
2012
|
0.80
|
|
144
|
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.
|
Genes Chromosomes Cancer
|
2014
|
0.79
|
|
145
|
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.
|
J Cancer Res Clin Oncol
|
2014
|
0.79
|
|
146
|
A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies.
|
Haematologica
|
2012
|
0.79
|
|
147
|
No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways.
|
Fam Cancer
|
2012
|
0.79
|
|
148
|
Expression of the p75 neurotrophin receptor in acute leukaemia.
|
Br J Haematol
|
2005
|
0.79
|
|
149
|
No evidence for ITSN1 loss in a patient with mental retardation and complex chromosomal rearrangements of 21q21-21q22.
|
Leuk Res
|
2013
|
0.79
|
|
150
|
Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis.
|
J Mol Med (Berl)
|
2014
|
0.79
|
|
151
|
MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice.
|
Acta Histochem
|
2011
|
0.79
|
|
152
|
Neurogenic transdifferentiation of human adipose-derived stem cells? A critical protocol reevaluation with special emphasis on cell proliferation and cell cycle alterations.
|
Histochem Cell Biol
|
2010
|
0.78
|
|
153
|
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.
|
BMC Genomics
|
2014
|
0.78
|
|
154
|
Histone methyltransferase Suv39h1 deficiency prevents Myc-induced chromosomal instability in murine myeloid leukemias.
|
Genes Chromosomes Cancer
|
2013
|
0.78
|
|
155
|
Bronchial epithelial cells as a new source for differential transcriptome analysis after lung transplantation.
|
Eur J Cardiothorac Surg
|
2009
|
0.78
|
|
156
|
Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.
|
Exp Hematol
|
2008
|
0.78
|
|
157
|
Interphase cytogenetic characterization of aberrations in the long arm of chromosome 1 in B-cell lymphoid malignancies.
|
Cancer Genet Cytogenet
|
2003
|
0.78
|
|
158
|
Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
|
Pathobiology
|
2006
|
0.77
|
|
159
|
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
|
Eur J Haematol
|
2014
|
0.77
|
|
160
|
Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer.
|
Int J Cancer
|
2014
|
0.77
|
|
161
|
Preferential loss of porcine chromosomes in reprogrammed interspecies cell hybrids.
|
Cell Reprogram
|
2010
|
0.76
|
|
162
|
Impact of the type of the BCR-ABL fusion transcript on the molecular response in pediatric patients with chronic myeloid leukemia.
|
Haematologica
|
2010
|
0.76
|
|
163
|
Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factor.
|
J Clin Oncol
|
2010
|
0.76
|
|
164
|
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
|
Pediatr Blood Cancer
|
2009
|
0.76
|
|
165
|
Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale.
|
Cancer Genet Cytogenet
|
2007
|
0.75
|
|
166
|
Mutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia?
|
Haematologica
|
2010
|
0.75
|
|
167
|
Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
|
Cancer Genet Cytogenet
|
2005
|
0.75
|
|
168
|
Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome.
|
Br J Haematol
|
2009
|
0.75
|
|
169
|
Simultaneous fluorescence immunophenotyping and FISH on tumor cells.
|
Methods Mol Biol
|
2002
|
0.75
|
|
170
|
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
|
Ann Hematol
|
2014
|
0.75
|
|
171
|
Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic Leukemia.
|
Cytogenet Genome Res
|
2017
|
0.75
|